Search

… Saturday, April 18, 2026 Semanti Mukherjee Awarded Chairman’s Prize Third-year student Semanti Mukherjee was awarded the Chairman’s Prize for her first-author paper In vitro mammalian cytotoxicological study of PAMAM dendrimers -towards quantitative structure activity relationships, published March 2009

Learn how a heralded clinical trial that made rectal cancer disappear for every participant is being expanded at Memorial Sloan Kettering Cancer Center. The trial uses only immunotherapy that targets a rare mutation — without the need for surgery, chemotherapy, or radiation.

… Wednesday, August 16, 2023 “I’d always dreamed of having a huge family.” For Kelly Spill, learning she had rectal cancer didn’t only mean facing a potentially life-threatening disease. The diagnosis also threatened many of the things she held dearest in life. Kelly was diagnosed at 28, just months after

A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.

… Wednesday, June 27, 2018 Summary Drug resistance is when a tumor stops responding to a targeted therapy. It is a serious problem in cancer treatment. Now, a multidisciplinary team has discovered a previously unknown mechanism of resistance to a new leukemia drug. Last summer, the US Food and Drug Administration

There is very little evidence that drinking hot beverages increases esophageal cancer risk.

… Thursday, August 4, 2022 Note: This story was originally published in 2019 and has been updated. It seems that almost every dietary habit has at some point been linked to an increased risk of cancer. In recent years, the idea has emerged that drinking very hot beverages like coffee and tea could contribute

New MSK research shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating tumors by delivering a viral-based immunotherapeutic to melanoma and breast cancer in mouse models.

… Thursday, May 18, 2023 New research from  Memorial Sloan Kettering Cancer Center (MSK)  shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating

Direna Alonso-Curbelo, PhD, of Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), has been named a winner of the 2021 Blavatnik Regional Awards for Young Scientists in the “Life Sciences” category.

… Wednesday, September 22, 2021 Direna Alonso-Curbelo, PhD , of Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), has been named a winner of the 2021 Blavatnik Regional Awards for Young Scientists in the “Life Sciences” category. Honoring outstanding postdoctoral scientists

Innovative imaging techniques shed light on intestinal damage that occurs after bone marrow transplant.

… Wednesday, July 17, 2019 VIDEO | 00:38 Mouse Intestinal Tissue This video of mouse intestinal tissue sheds light on graft-versus-host disease. The imaging technique shows clearly for the first time that after bone marrow transplantation the invading T cells from the donor (green) go mainly to the crypt

Meet Jenny Solomon, who uses acting techniques to help people cope with cancer.

… Tuesday, August 28, 2018 Summary Using drama can help people make sense of their emotions in an engaging way. Jenny Solomon shares how theater arts can be a creative outlet for people affected by cancer. Inside the pediatrics inpatient unit at Memorial Sloan Kettering, Gloria Habib had turned into a

Al Roker, anchor of NBC’s TODAY, shared an update on his successful treatment for prostate cancer at MSK in a recent segment on the broadcast. 

… Tuesday, November 17, 2020 Al Roker, anchor of NBC’s TODAY , shared an update on his successful treatment for prostate cancer at Memorial Sloan Kettering (MSK) in a recent segment on the broadcast . Al had previously announced his diagnosis on the show prior to having surgery for the disease. “Al’s surgery

An international group of investigators led by scientists at Memorial Sloan Kettering Cancer Center and the National Cancer Institute has identified a new genetic marker of risk for breast cancer. Women with this DNA variation are at a 1.4 times greater risk of developing breast cancer compared to those without the variation.

… Monday, March 3, 2008 An international group of investigators led by scientists at Memorial Sloan Kettering Cancer Center (MSKCC) and the National Cancer Institute has identified a new genetic marker of risk for breast cancer . Women with this DNA variation are at a 1.4 times greater risk of developing